Annual Long Term Debt
$18.37 B
-$1.00 B-5.18%
December 1, 2024
Summary
- As of February 7, 2025, GSK annual long term debt is $18.37 billion, with the most recent change of -$1.00 billion (-5.18%) on December 1, 2024.
- During the last 3 years, GSK annual long term debt has fallen by -$9.40 billion (-33.85%).
- GSK annual long term debt is now -42.47% below its all-time high of $31.92 billion, reached on December 31, 2020.
Performance
GSK Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$17.72 B
+$551.06 M+3.21%
September 30, 2024
Summary
- As of February 7, 2025, GSK quarterly long term debt is $17.72 billion, with the most recent change of +$551.06 million (+3.21%) on September 30, 2024.
- Over the past year, GSK quarterly long term debt has dropped by -$1.79 billion (-9.17%).
- GSK quarterly long term debt is now -53.84% below its all-time high of $38.39 billion, reached on March 31, 2022.
Performance
GSK Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
GSK Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.2% | -9.2% |
| 3 y3 years | -33.9% | -53.8% |
| 5 y5 years | -40.6% | -53.8% |
GSK Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.9% | at low | -53.8% | +3.2% |
| 5 y | 5-year | -42.5% | at low | -53.8% | +3.2% |
| alltime | all time | -42.5% | >+9999.0% | -53.8% | >+9999.0% |
GSK Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $18.37 B(-5.2%) | - |
| Sep 2024 | - | $17.72 B(+3.2%) |
| Jun 2024 | - | $17.17 B(-10.3%) |
| Mar 2024 | - | $19.13 B(-1.2%) |
| Dec 2023 | $19.37 B(-6.0%) | $19.37 B(-0.7%) |
| Sep 2023 | - | $19.51 B(-0.5%) |
| Jun 2023 | - | $19.62 B(-4.8%) |
| Mar 2023 | - | $20.61 B(-0.0%) |
| Dec 2022 | $20.62 B(-25.7%) | $20.62 B(-4.5%) |
| Sep 2022 | - | $21.58 B(-5.3%) |
| Jun 2022 | - | $22.78 B(-40.7%) |
| Mar 2022 | - | $38.39 B(+38.3%) |
| Dec 2021 | $27.76 B(-13.0%) | $27.76 B(-0.3%) |
| Sep 2021 | - | $27.84 B(-1.6%) |
| Jun 2021 | - | $28.29 B(-10.7%) |
| Mar 2021 | - | $31.68 B(-0.8%) |
| Dec 2020 | $31.92 B(+3.2%) | $31.92 B(+6.4%) |
| Sep 2020 | - | $30.02 B(-5.2%) |
| Jun 2020 | - | $31.67 B(+3.5%) |
| Mar 2020 | - | $30.60 B(-1.1%) |
| Dec 2019 | $30.93 B(+20.2%) | $30.93 B(+1.3%) |
| Sep 2019 | - | $30.52 B(+3.3%) |
| Jun 2019 | - | $29.54 B(-3.0%) |
| Mar 2019 | - | $30.45 B(+18.4%) |
| Dec 2018 | $25.72 B(+33.4%) | $25.72 B(-20.4%) |
| Sep 2018 | - | $32.32 B(+0.5%) |
| Jun 2018 | - | $32.15 B(+63.7%) |
| Mar 2018 | - | $19.64 B(+1.9%) |
| Dec 2017 | $19.28 B(+7.0%) | $19.28 B(+0.4%) |
| Sep 2017 | - | $19.20 B(+20.4%) |
| Jun 2017 | - | $15.95 B(-12.4%) |
| Mar 2017 | - | $18.22 B(+1.1%) |
| Dec 2016 | $18.01 B(-20.7%) | $18.01 B(-9.8%) |
| Sep 2016 | - | $19.96 B(-1.8%) |
| Jun 2016 | - | $20.32 B(-10.2%) |
| Mar 2016 | - | $22.63 B(-0.3%) |
| Dec 2015 | $22.70 B(-7.9%) | $22.70 B(-0.8%) |
| Sep 2015 | - | $22.89 B(-0.9%) |
| Jun 2015 | - | $23.11 B(+2.5%) |
| Mar 2015 | - | $22.54 B(-8.6%) |
| Dec 2014 | $24.66 B(-3.3%) | $24.66 B(+11.5%) |
| Sep 2014 | - | $22.12 B(-10.5%) |
| Jun 2014 | - | $24.71 B(-3.5%) |
| Mar 2014 | - | $25.60 B(+0.5%) |
| Dec 2013 | $25.49 B(+7.5%) | $25.49 B(+0.7%) |
| Sep 2013 | - | $25.31 B(+1.8%) |
| Jun 2013 | - | $24.86 B(-5.4%) |
| Mar 2013 | - | $26.29 B(+10.9%) |
| Dec 2012 | $23.71 B(+26.1%) | $23.71 B(+9.6%) |
| Sep 2012 | - | $21.63 B(+2.7%) |
| Jun 2012 | - | $21.06 B(+10.1%) |
| Mar 2012 | - | $19.13 B(+1.8%) |
| Dec 2011 | $18.80 B(-17.7%) | $18.80 B(-15.1%) |
| Sep 2011 | - | $22.16 B(-3.1%) |
| Jun 2011 | - | $22.87 B(-4.0%) |
| Mar 2011 | - | $23.83 B(+4.3%) |
| Dec 2010 | $22.86 B | $22.86 B(-2.5%) |
| Sep 2010 | - | $23.45 B(+5.7%) |
| Jun 2010 | - | $22.19 B(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2010 | - | $23.10 B(-3.4%) |
| Dec 2009 | $23.91 B(+7.2%) | $23.91 B(-0.6%) |
| Sep 2009 | - | $24.05 B(+11.8%) |
| Jun 2009 | - | $21.51 B(-0.7%) |
| Mar 2009 | - | $21.67 B(-2.9%) |
| Dec 2008 | $22.31 B(+58.8%) | $22.31 B(-2.2%) |
| Sep 2008 | - | $22.81 B(-8.9%) |
| Jun 2008 | - | $25.04 B(+55.6%) |
| Mar 2008 | - | $16.10 B(+14.6%) |
| Dec 2007 | $14.05 B(+50.4%) | $14.05 B(+40.7%) |
| Sep 2007 | - | $9.99 B(-1.0%) |
| Jun 2007 | - | $10.09 B(+7.1%) |
| Mar 2007 | - | $9.42 B(+0.8%) |
| Dec 2006 | $9.34 B(+3.1%) | $9.34 B(+2.8%) |
| Sep 2006 | - | $9.08 B(+0.8%) |
| Jun 2006 | - | $9.02 B(-1.9%) |
| Mar 2006 | - | $9.19 B(+1.4%) |
| Dec 2005 | $9.06 B(+7.8%) | $9.06 B(-1.4%) |
| Sep 2005 | - | $9.20 B(-1.4%) |
| Jun 2005 | - | $9.33 B(+21.0%) |
| Mar 2005 | - | $7.71 B(-8.2%) |
| Dec 2004 | $8.40 B(+28.9%) | $8.40 B(-6.7%) |
| Sep 2004 | - | $9.01 B(+0.9%) |
| Jun 2004 | - | $8.93 B(+34.8%) |
| Mar 2004 | - | $6.63 B(+1.6%) |
| Dec 2003 | $6.52 B(+30.8%) | $6.52 B(+5.9%) |
| Sep 2003 | - | $6.16 B(-2.6%) |
| Jun 2003 | - | $6.32 B(+35.7%) |
| Mar 2003 | - | $4.66 B(-6.6%) |
| Dec 2002 | $4.98 B(+62.9%) | $4.98 B(+18.5%) |
| Sep 2002 | - | $4.21 B(+14.0%) |
| Jun 2002 | - | $3.69 B(+5.1%) |
| Mar 2002 | - | $3.51 B(+14.8%) |
| Dec 2001 | $3.06 B(+17.2%) | $3.06 B(+37.0%) |
| Sep 2001 | - | $2.23 B(+1.3%) |
| Jun 2001 | - | $2.20 B(-5.5%) |
| Mar 2001 | - | $2.33 B(-10.6%) |
| Dec 2000 | $2.61 B(+28.2%) | $2.61 B(-10.1%) |
| Sep 2000 | - | $2.91 B(-1.6%) |
| Jun 2000 | - | $2.95 B(-2.1%) |
| Mar 2000 | - | $3.01 B(+48.0%) |
| Dec 1999 | $2.04 B(-31.8%) | $2.04 B(-20.1%) |
| Jun 1999 | - | $2.55 B(-14.5%) |
| Dec 1998 | $2.98 B(-2.1%) | $2.98 B(-0.3%) |
| Jun 1998 | - | $2.99 B(-1.9%) |
| Dec 1997 | $3.05 B(+5.6%) | $3.05 B(+5.6%) |
| Dec 1996 | $2.89 B(+27.0%) | $2.89 B(-44.5%) |
| Dec 1995 | $2.27 B(-56.3%) | - |
| Jun 1995 | - | $5.20 B(+1141.0%) |
| Jun 1995 | $5.20 B(+1141.0%) | - |
| Jun 1994 | $419.02 M(+31.0%) | $419.02 M(+31.0%) |
| Jun 1993 | $319.84 M(+22.9%) | $319.84 M(+22.9%) |
| Jun 1992 | $260.30 M(+14.6%) | $260.30 M(+14.6%) |
| Jun 1991 | $227.11 M(+196.1%) | $227.11 M(+196.1%) |
| Jun 1990 | $76.69 M(+54.6%) | $76.69 M(+54.6%) |
| Jun 1989 | $49.59 M(+141.8%) | $49.59 M(+141.8%) |
| Jun 1988 | $20.51 M(-2.0%) | $20.51 M(-2.0%) |
| Jun 1987 | $20.93 M(+36.7%) | $20.93 M(+36.7%) |
| Jun 1986 | $15.31 M | $15.31 M |
FAQ
- What is GSK annual long term debt?
- What is the all time high annual long term debt for GSK?
- What is GSK annual long term debt year-on-year change?
- What is GSK quarterly long term debt?
- What is the all time high quarterly long term debt for GSK?
- What is GSK quarterly long term debt year-on-year change?
What is GSK annual long term debt?
The current annual long term debt of GSK is $18.37 B
What is the all time high annual long term debt for GSK?
GSK all-time high annual long term debt is $31.92 B
What is GSK annual long term debt year-on-year change?
Over the past year, GSK annual long term debt has changed by -$1.00 B (-5.18%)
What is GSK quarterly long term debt?
The current quarterly long term debt of GSK is $17.72 B
What is the all time high quarterly long term debt for GSK?
GSK all-time high quarterly long term debt is $38.39 B
What is GSK quarterly long term debt year-on-year change?
Over the past year, GSK quarterly long term debt has changed by -$1.79 B (-9.17%)